When was xcopri approved?

When was Xcopri (cenobamate) approved?

Xcopri (cenobamate) was approved by the U.S. Food and Drug Administration (FDA) on November 10, 2019 for the treatment of partial-onset seizures in adults with epilepsy. [1]

Has Xcopri been approved for other uses since then?

Yes. After the initial approval, Xcopri later received additional FDA approval for broader seizure indications and/or different patient populations (based on subsequent label updates), but the original FDA approval date remains November 10, 2019. [1]

What’s the approval history detail people usually look for?

Most people searching for “when was Xcopri approved” are looking for the first FDA “approval letter” date. That first approval date is November 10, 2019. [1]

Sources
[1] https://www.drugpatentwatch.com/patent/xcopri